Vasileios Angelis
-
- HER2/EGFR in Cancer Research 3
- COVID-19 and healthcare impacts 2
- Peptidase Inhibition and Analysis 1
-
- Advanced Breast Cancer Therapies 4
-
- Economic and Financial Impacts of Cancer 2
-
- Breast Cancer Treatment Studies 1
-
- Immune Response and Inflammation 1
-
- Healthcare cost, quality, practices 1
- Co-authors
- Alicia OkinesSusannah StanwayE. GoodeAlistair RingAlexander R. LyonMaría Sol AndrésMark AllenKathrin Maedler
- Partner nations
- United KingdomItalyGermany
In The Last Decade
Vasileios Angelis
9 papers receiving 84 citations
Peers
Comparison fields: 5 of 38
- Oncology 54
- Cardiology and Cardiovascular Medicine 39
- Radiology, Nuclear Medicine and Imaging 26
- Infectious Diseases 10
- Applied Microbiology and Biotechnology 1
Countries citing papers authored by Vasileios Angelis
This map shows the geographic impact of Vasileios Angelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasileios Angelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasileios Angelis more than expected).
Fields of papers citing papers by Vasileios Angelis
This network shows the impact of papers produced by Vasileios Angelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasileios Angelis. The network helps show where Vasileios Angelis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vasileios Angelis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 45 | |
| 6 | 2020 | 21 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 1 | |
| 9 | [Quality control of spirometric tests used in health surveillance for occupational exposure risk, in the province of Viterbo]. | 2001 | 0 |
| 10 | 1988 | 2 |
About Vasileios Angelis
Vasileios Angelis is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 10 papers that have together received 84 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (3 papers), Economic and Financial Impacts of Cancer (2 papers), COVID-19 and healthcare impacts (2 papers), Peptidase Inhibition and Analysis (1 paper), Breast Cancer Treatment Studies (1 paper), Immune Response and Inflammation (1 paper) and Healthcare cost, quality, practices (1 paper). The work is most often cited by research in Oncology (54 citations), Cardiology and Cardiovascular Medicine (39 citations) and Radiology, Nuclear Medicine and Imaging (26 citations). Vasileios Angelis has collaborated with scholars based in United Kingdom, Italy and Germany. Frequent co-authors include Alicia Okines, Susannah Stanway, E. Goode, Alistair Ring, Alexander R. Lyon, María Sol Andrés, Mark Allen, Kathrin Maedler, Karla A. Lee and Amin Ardestani. Their work appears in journals such as Annals of Oncology, Cancers, Frontiers in Endocrinology, Breast Cancer Research and Treatment and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.